Literature DB >> 33326565

Mechanisms of Colonization Resistance Against Clostridioides difficile.

Colleen M Pike1, Casey M Theriot1.   

Abstract

Clostridioides difficile is an urgent antimicrobial-resistant bacterium, causing mild to moderate and sometimes life-threatening disease. Commensal gut microbes are critical for providing colonization resistance against C difficile and can be leveraged as non-antibiotic alternative therapeutics for the prevention and treatment of C difficile infection.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Clostridioides difficile; bacteria; bile acids; microbiota; short-chain fatty acids

Mesh：

Substances：

Year:  2021        PMID： 33326565      PMCID： PMC8206795          DOI： 10.1093/infdis/jiaa408

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  63 in total

1.  Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage.

Authors:  Mizuho Hasegawa; Shoko Yada; Meng Zhen Liu; Nobuhiko Kamada; Raúl Muñoz-Planillo; Nhu Do; Gabriel Núñez; Naohiro Inohara
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics.

Authors:  Hasna Hanchi; Riadh Hammami; Hélène Gingras; Rim Kourda; Michel G Bergeron; Jeannette Ben Hamida; Marc Ouellette; Ismail Fliss
Journal:  Future Microbiol       Date:  2017-02-20       Impact factor: 3.165

3.  Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

Authors:  Mary C Rea; Clarissa S Sit; Evelyn Clayton; Paula M O'Connor; Randy M Whittal; Jing Zheng; John C Vederas; R Paul Ross; Colin Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-30       Impact factor: 11.205

Review 4.  Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis.

Authors:  Claudia Slimings; Thomas V Riley
Journal:  J Antimicrob Chemother       Date:  2013-12-08       Impact factor: 5.790

5.  Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Stephen J Allen; Kathie Wareham; Duolao Wang; Caroline Bradley; Hayley Hutchings; Wyn Harris; Anjan Dhar; Helga Brown; Alwyn Foden; Michael B Gravenor; Dietrich Mack
Journal:  Lancet       Date:  2013-08-08       Impact factor: 79.321

6.  Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.

Authors:  Jenessa A Winston; Alissa J Rivera; Jingwei Cai; Rajani Thanissery; Stephanie A Montgomery; Andrew D Patterson; Casey M Theriot
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

7.  Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile.

Authors:  Alyxandria M Schubert; Hamide Sinani; Patrick D Schloss
Journal:  mBio       Date:  2015-07-14       Impact factor: 7.867

8.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.

Authors:  Casey M Theriot; Mark J Koenigsknecht; Paul E Carlson; Gabrielle E Hatton; Adam M Nelson; Bo Li; Gary B Huffnagle; Jun Z Li; Vincent B Young
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

9.  Gut microbiome structure and metabolic activity in inflammatory bowel disease.

Authors:  Eric A Franzosa; Alexandra Sirota-Madi; Julian Avila-Pacheco; Nadine Fornelos; Henry J Haiser; Stefan Reinker; Tommi Vatanen; A Brantley Hall; Himel Mallick; Lauren J McIver; Jenny S Sauk; Robin G Wilson; Betsy W Stevens; Justin M Scott; Kerry Pierce; Amy A Deik; Kevin Bullock; Floris Imhann; Jeffrey A Porter; Alexandra Zhernakova; Jingyuan Fu; Rinse K Weersma; Cisca Wijmenga; Clary B Clish; Hera Vlamakis; Curtis Huttenhower; Ramnik J Xavier
Journal:  Nat Microbiol       Date:  2018-12-10       Impact factor: 17.745

10.  Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria.

Authors:  Valentine Cleusix; Christophe Lacroix; Sabine Vollenweider; Marc Duboux; Gwenaelle Le Blay
Journal:  BMC Microbiol       Date:  2007-11-12       Impact factor: 3.605
View more
  7 in total

Review 1.  Computational approaches to understanding Clostridioides difficile metabolism and virulence.

Authors:  Matthew L Jenior; Jason A Papin
Journal:  Curr Opin Microbiol       Date:  2021-11-25       Impact factor: 7.934

2.  Gut metabolites predict Clostridioides difficile recurrence.

Authors:  Jennifer J Dawkins; Jessica R Allegretti; Travis E Gibson; Emma McClure; Mary Delaney; Lynn Bry; Georg K Gerber
Journal:  Microbiome       Date:  2022-06-09       Impact factor: 16.837

3.  The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance.

Authors:  Ryan T Ranallo; L Clifford McDonald; Alison Laufer Halpin; Thomas Hiltke; Vincent B Young
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

4.  Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.

Authors:  Madeline R Barron; Kelly L Sovacool; Lisa Abernathy-Close; Kimberly C Vendrov; Alexandra K Standke; Ingrid L Bergin; Patrick D Schloss; Vincent B Young
Journal:  mBio       Date:  2022-07-28       Impact factor: 7.786

5.  Gut community alterations associated with Clostridioides difficile colonization in hospitalized gastroenterological patients with or without inflammatory bowel disease.

Authors:  Aleksander Mahnic; Spela Pintar; Pavel Skok; Maja Rupnik
Journal:  Front Microbiol       Date:  2022-09-06       Impact factor: 6.064

Review 6.  Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Livio Enrico Del Vecchio; Marcello Fiorani; Ege Tohumcu; Stefano Bibbò; Serena Porcari; Maria Cristina Mele; Marco Pizzoferrato; Antonio Gasbarrini; Giovanni Cammarota; Gianluca Ianiro
Journal:  Microorganisms       Date:  2022-06-29

7.  What's a Biofilm?-How the Choice of the Biofilm Model Impacts the Protein Inventory of Clostridioides difficile.

Authors:  Madita Brauer; Christian Lassek; Christian Hinze; Juliane Hoyer; Dörte Becher; Dieter Jahn; Susanne Sievers; Katharina Riedel
Journal:  Front Microbiol       Date:  2021-06-10       Impact factor: 5.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.